Concurrent CD5-negative small lymphocytic lymphoma (SLL) and CD5-positive metastatic carcinoma of unknown primary in a lymph node biopsy

Journal of Hematopathology - Tập 6 - Trang 45-50 - 2012
Juehua Gao1, LoAnn Peterson1, Yanming Zhang1, Yi-Hua Chen
1Feinberg School of Medicine, Northwestern University, Chicago, USA

Tóm tắt

CD5 expression is considered a key marker for the diagnosis of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL). We report an unusual case of CD5-negative (CD5−) SLL with a concurrent CD5-positive (CD5+) adenocarcinoma of unknown primary involving the same lymph node. An 83-year-old woman with a history of CD5− B cell lymphoma diagnosed on a core biopsy of a cervical lymph node presented with jaundice and was found to have a 2.5-cm pancreatic mass. A fine needle aspiration of the mass revealed a CD5− monotypic B cell population. A subsequent excisional biopsy of a cervical lymph node showed morphologic findings typical for SLL, including the presence of multiple proliferation centers. However, the neoplastic lymphocytes were negative for CD5 by both flow cytometric analysis and immunohistochemistry. Interestingly, multifocal metastatic adenocarcinoma was identified and was positive for CD5. Lack of CD5 expression often leads to the exclusion of CLL/SLL, particularly in small biopsy samples. However, rare cases of CD5− CLL/SLL have been reported. In addition, CD5 is not an exclusive marker for lymphoid cells; its expression has been observed in several non-hematopoietic neoplasms. This report briefly reviewed and discussed CD5− CLL/SLL and CD5+ carcinoma reported in the literature.

Tài liệu tham khảo

Muller-Hermelink HK, Montserrat E, Catovsky D, Campo E, Harris NL, Stein H (2008) Chronic lymphocytic leukemia/small lymphocytic lymphoma. In: Swerdlow S, Campo E, Harris NL, Jaffe E, Pileri S, Stein S, Thiele J, Vardiman J (eds) WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. International Agency for Research on Cancer (IARC), Lyon Tandon B, Peterson L, Gao J, Nelson B, Ma S, Rosen S, Chen YH (2011) Nuclear overexpression of lymphoid-enhancer-binding factor 1 identifies chronic lymphocytic leukemia/small lymphocytic lymphoma in small B-cell lymphomas. Mod Pathol. doi: 10.1038/modpathol.2011.103 Cartron G, Linassier C, Bremond JL, Desablens B, Georget MT, Fimbel B, Luthier F, Dutel JL, Lamagnere JP, Colombat P (1998) CD5 negative B-cell chronic lymphocytic leukemia: clinical and biological features of 42 cases. Leuk Lymphoma 31(1–2):209–216. doi:10.3109/10428199809057600 Huang JC, Finn WG, Goolsby CL, Variakojis D, Peterson LC (1999) CD5− small B-cell leukemias are rarely classifiable as chronic lymphocytic leukemia. Am J Clin Pathol 111(1):123–130 Sheikh SS, Kallakury BV, Al-Kuraya KA, Meck J, Hartmann DP, Bagg A (2002) CD5-negative, CD10-negative small B-cell leukemia: variant of chronic lymphocytic leukemia or a distinct entity? Am J Hematol 71(4):306–310. doi:10.1002/ajh.10222 Criel A, Michaux L, De Wolf-Peeters C (1999) The concept of typical and atypical chronic lymphocytic leukaemia. Leuk Lymphoma 33(1–2):33–45. doi:10.3109/10428199909093723 Bogner PN, Su LD, Fullen DR (2005) Cluster designation 5 staining of normal and non-lymphoid neoplastic skin. J Cutan Pathol 32(1):50–54. doi:10.1111/j.0303-6987.2005.00253.x Tateyama H, Eimoto T, Tada T, Hattori H, Murase T, Takino H (1999) Immunoreactivity of a new CD5 antibody with normal epithelium and malignant tumors including thymic carcinoma. Am J Clin Pathol 111(2):235–240 Reimann JD, Dorfman DM, Nose V (2006) Carcinoma showing thymus-like differentiation of the thyroid (CASTLE): a comparative study: evidence of thymic differentiation and solid cell nest origin. Am J Surg Pathol 30(8):994–1001 Chu PG, Arber DA, Weiss LM (2003) Expression of T/NK-cell and plasma cell antigens in nonhematopoietic epithelioid neoplasms. An immunohistochemical study of 447 cases. Am J Clin Pathol 120(1):64–70. doi:10.1309/48KC-17WA-U69B-TBXQ Walsh R, Peston D, Shousha S (2001) Comparison of immunoperoxidase staining of 3 different types of CD5 antibodies in a spectrum of breast lesions. Arch Pathol Lab Med 125(6):781–784. doi:10.1043/0003-9985(2001) 125<0781:COISOD>2.0.CO;2 Manusow D, Weinerman BH (1975) Subsequent neoplasia in chronic lymphocytic leukemia. JAMA 232(3):267–269 Zhang H, Gupta G, Yang XY, Rosenbluth R, Bhattacharyya PK (2009) A unique case of merkel cell carcinoma and chronic lymphocytic leukaemia presenting in a single cutaneous lesion (collision tumour). BMJ Case Rep 2009. doi:10.1136/bcr.09.2008.1016 Becker DJ, Sevilla DW, O'Connor O (2010) Concurrent and apposed hepatocellular carcinoma and small lymphocytic lymphoma/chronic lymphocytic leukemia in a patient with hepatitis C virus. Acta Haematol 123(2):77–80. doi:10.1159/000268853 Chu PG, Huang Q, Weiss LM (2005) Incidental and concurrent malignant lymphomas discovered at the time of prostatectomy and prostate biopsy: a study of 29 cases. Am J Surg Pathol 29(5):693–699 Mikami Y, Maehata K, Fujiwara K, Sasano H (2004) Squamous cell carcinoma of the uterine cervix in association with stage 0 chronic lymphocytic leukemia/small lymphocytic lymphoma. Gynecol Oncol 92(3):974–977. doi:10.1016/j.ygyno.2003.11.021